AIM: To evaluate the hepatic function in patients with severe acute respiratory syndrome (SARS) and possible causes of hepatic disorder in these patients. METHODS: One hundred and eighty-two patients with SARS were employed in a retrospective study that investigated hepatic dysfunction. Liver alanine aminotransferase (ALT), aspartate aminotransferase (AST) and lactic dehydrogenase (LDH) were analyzed in these patients. Patients with different hospital treatments were further investigated. RESULTS: Of the 182 patients, 128(70.3%) had abnormal ALT activity, 57(31.3%) had abnormal AST activity and 87(47.8%) had abnormal LDH activity. The peak of elevated hepatic enzyme activities occurred between the sixth day and the tenth day after the first day of reported fever. Of the 182 patients, 160(87.9%) had been treated with antibiotics, 137(75.2%) with Ribavirin, and 115(63.2%) with methylpredisolone. There was no statistically significant correlation between the duration of Ribavirin treatment and hepatic dysfunction. CONCLUSION: Abnormal liver functions were common in patients with SARS and could be associated with virus replication in the liver.
AIM: To evaluate the hepatic function in patients with severe acute respiratory syndrome (SARS) and possible causes of hepatic disorder in these patients. METHODS: One hundred and eighty-two patients with SARS were employed in a retrospective study that investigated hepatic dysfunction. Liver alanine aminotransferase (ALT), aspartate aminotransferase (AST) and lactic dehydrogenase (LDH) were analyzed in these patients. Patients with different hospital treatments were further investigated. RESULTS: Of the 182 patients, 128(70.3%) had abnormal ALT activity, 57(31.3%) had abnormal AST activity and 87(47.8%) had abnormal LDH activity. The peak of elevated hepatic enzyme activities occurred between the sixth day and the tenth day after the first day of reported fever. Of the 182 patients, 160(87.9%) had been treated with antibiotics, 137(75.2%) with Ribavirin, and 115(63.2%) with methylpredisolone. There was no statistically significant correlation between the duration of Ribavirin treatment and hepatic dysfunction. CONCLUSION:Abnormal liver functions were common in patients with SARS and could be associated with virus replication in the liver.
Authors: Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr Journal: N Engl J Med Date: 2003-04-10 Impact factor: 91.245
Authors: Susan M Poutanen; Donald E Low; Bonnie Henry; Sandy Finkelstein; David Rose; Karen Green; Raymond Tellier; Ryan Draker; Dena Adachi; Melissa Ayers; Adrienne K Chan; Danuta M Skowronski; Irving Salit; Andrew E Simor; Arthur S Slutsky; Patrick W Doyle; Mel Krajden; Martin Petric; Robert C Brunham; Allison J McGeer Journal: N Engl J Med Date: 2003-03-31 Impact factor: 91.245
Authors: C B Hall; J T McBride; E E Walsh; D M Bell; C L Gala; S Hildreth; L G Ten Eyck; W J Hall Journal: N Engl J Med Date: 1983-06-16 Impact factor: 91.245
Authors: J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen Journal: Lancet Date: 2003-04-19 Impact factor: 79.321
Authors: Thijs Kuiken; Ron A M Fouchier; Martin Schutten; Guus F Rimmelzwaan; Geert van Amerongen; Debby van Riel; Jon D Laman; Ton de Jong; Gerard van Doornum; Wilina Lim; Ai Ee Ling; Paul K S Chan; John S Tam; Maria C Zambon; Robin Gopal; Christian Drosten; Sylvie van der Werf; Nicolas Escriou; Jean-Claude Manuguerra; Klaus Stöhr; J S Malik Peiris; Albert D M E Osterhaus Journal: Lancet Date: 2003-07-26 Impact factor: 79.321
Authors: Thomas C Greenough; Angela Carville; James Coderre; Mohan Somasundaran; John L Sullivan; Katherine Luzuriaga; Keith Mansfield Journal: Am J Pathol Date: 2005-08 Impact factor: 4.307
Authors: Michał Kukla; Karolina Skonieczna-Żydecka; Katarzyna Kotfis; Dominika Maciejewska; Igor Łoniewski; Luis F Lara; Monika Pazgan-Simon; Ewa Stachowska; Mariusz Kaczmarczyk; Anastasios Koulaouzidis; Wojciech Marlicz Journal: J Clin Med Date: 2020-05-11 Impact factor: 4.241
Authors: Wai S Chan; Chun Wu; Sammy C S Chow; To Cheung; Ka-Fai To; Wai-Keung Leung; Paul K S Chan; Kam-Cheong Lee; Ho-Keung Ng; Deborah M Y Au; Anthony W I Lo Journal: Mod Pathol Date: 2005-11 Impact factor: 7.842
Authors: Yan Deng; Wei Liu; Kui Liu; Yuan-Yuan Fang; Jin Shang; Ling Zhou; Ke Wang; Fan Leng; Shuang Wei; Lei Chen; Hui-Guo Liu Journal: Chin Med J (Engl) Date: 2020-06-05 Impact factor: 2.628
Authors: Anna Bertolini; Ivo P van de Peppel; Frank A J A Bodewes; Han Moshage; Alberto Fantin; Fabio Farinati; Romina Fiorotto; Johan W Jonker; Mario Strazzabosco; Henkjan J Verkade; Giulia Peserico Journal: Hepatology Date: 2020-10-20 Impact factor: 17.298
Authors: Miriam E R Darnell; Ewan P Plant; Hisayoshi Watanabe; Russ Byrum; Marisa St Claire; Jerrold M Ward; Deborah R Taylor Journal: J Infect Dis Date: 2007-09-27 Impact factor: 5.226